The average 5-year survival rate in patients with APN/CD13 expression has also been reported to be considerably lower than that in patients without the expression of APN/CD13, in a variety of cancers such as colon cancer [60] and osteosarcomas [5]. Here, ANPEP is linked to osteosarcoma.